Pharmacogenomic biomarkers for personalized cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacogenomic biomarkers for personalized cancer treatment

Published:2015-01-26 Issue:2 Volume:277 Page:201-217
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Rodríguez-Antona C.¹²,Taron M.³

Affiliation:

1. Hereditary Endocrine Cancer Group; Spanish National Cancer Research Centre (CNIO); Madrid Spain

2. ISCIII Center for Biomedical Research on Rare Diseases (CIBERER); Madrid Spain

3. Medical Oncology Service and Laboratory; Pangaea Biotech SL; Quiron Dexeus Universitary Hospital; Barcelona Spain

Funder

Spanish Ministry of Economy and Competitiveness

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12321/fullpdf

Reference102 articles.

1. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies;Lazarou;JAMA,1998

2. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study;Gray;Lancet,2007

3. Tumor control versus adverse events with targeted anticancer therapies;Keefe;Nat Rev Clin Oncol,2012

4. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects;Sim;Pharmacogenomics J,2013

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of MSH6 augments the antineoplastic efficacy of cisplatin in non-small cell lung cancer as autophagy modulator;Chemico-Biological Interactions;2024-10

2. PCAS: An Integrated Tool for Multi-Dimensional Cancer Research Utilizing Clinical Proteomic Tumor Analysis Consortium Data;International Journal of Molecular Sciences;2024-06-18

3. Clinical pharmacists’ knowledge, attitude, perception, and beliefs about the role of pharmacogenetic testing for genes polymorphisms when prescribing mercaptopurine;Saudi Pharmaceutical Journal;2024-04

4. A conceptual framework for cautious escalation of anticancer treatment: How to optimize overall benefit and obviate the need for de-escalation trials;Cancer Treatment Reviews;2024-03

5. Role of Pharmacogenomics in Tumor and Therapeutic Outcomes;Handbook of Oncobiology: From Basic to Clinical Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3